Insider Transactions Reported by 16 Insiders of Sigilon Therapeutics, Inc.

Location
Cambridge, MA

There are no Buy or Sell transactions made by insiders since 04 Jan 2025

Sigilon Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
DANIEL GRIFFITH ANDERSON Director $30,171,552 02 Jun 2021
May Orfali Chief Medical Officer $66,439 18 Feb 2022
Brooke Story Director $59,051 26 May 2022
ELI LILLY & Co 10%+ Owner $1,492 11 Aug 2023
Philip Ashton-Rickardt Chief Scientific Officer 11 Aug 2023
ROBERT R. RUFFOLO Director 11 Aug 2023
Flagship Ventures Fund V General Partner LLC 10%+ Owner 11 Aug 2023
John Cox Director 11 Aug 2023
Josias Pontes Chief Financial Officer 11 Aug 2023
Qing Sarah Yuan Ctoo 11 Aug 2023
Douglas G. Cole Director 11 Aug 2023
Coelho Rogerio Vivaldi PRESIDENT AND CEO, Director 11 Aug 2023
Eric D. Shaff Director 11 Aug 2023
Kavita Patel Director 11 Aug 2023
Stephen N. Oesterle Director 11 Aug 2023
Matthew Paul Kowalsky Chief Of Staff And Clo 11 Aug 2023

Recent Insider Transactions by Companies or Individuals for Sigilon Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.